TY - JOUR
T1 - E4BP4-mediated inhibition of T follicular helper cell differentiation is compromised in autoimmune diseases
AU - Wang, Zijun
AU - Zhao, Ming
AU - Yin, Jinghua
AU - Liu, Limin
AU - Hu, Longyuan
AU - Huang, Yi
AU - Liu, Aiyun
AU - Ouyang, Jiajun
AU - Min, Xiaoli
AU - Rao, Shijia
AU - Zhou, Wenhui
AU - Wu, Haijing
AU - Yoshimura, Akihiko
AU - Lu, Qianjin
N1 - Funding Information:
The present research was supported by the National Natural Science Foundation of China (projects 81522038, 81430074, 81830097, 81874243, and 81903221), the innovation project of the Chinese academy of medical sciences (Research Unit 2019-I2M-5-033), the Key project for international and regional cooperation in science and technology innovation of Hunan province (2019WK2081), the Project for leading talents in science and technology in Hunan province (2019RS3003), and the Fundamental Research Funds for the Central Universities of Central South University (2018zzts262). The present research was also supported by JSPS KAKENHI (S) JP17H06175, Challenging Research (P) JP18H05376, and AMED-CREST JP19gm1110009 grants to Akihiko Yoshimura.
Publisher Copyright:
Copyright: © 2020, American Society for Clinical Investigation.
PY - 2020/7/1
Y1 - 2020/7/1
N2 - T follicular helper (Tfh) cells are indispensable for the formation of germinal center (GC) reactions, whereas T follicular regulatory (Tfr) cells inhibit Tfh-mediated GC responses. Aberrant activation of Tfh cells contributes substantially to the pathogenesis of autoimmune diseases, such as systemic lupus erythematosus (SLE). Nonetheless, the molecular mechanisms mitigating excessive Tfh cell differentiation are not fully understood. Herein we demonstrate that the adenovirus E4 promoter-binding protein (E4BP4) mediates a feedback loop and acts as a transcriptional brake to inhibit Tfh cell differentiation. Furthermore, we show that such an immunological mechanism is compromised in patients with SLE. Establishing mice with either conditional knockout (cKO) or knockin (cKI) of the E4bp4 gene in T cells reveals that E4BP4 strongly inhibits Tfh cell differentiation. Mechanistically, E4BP4 regulates Bcl6 transcription by recruiting the repressive epigenetic modifiers HDAC1 and EZH2. E4BP4 phosphorylation site mutants have limited capability with regard to inhibiting Tfh cell differentiation. In SLE, we detected impaired phosphorylation of E4BP4, finding that this compromised transcription factor is positively correlated with disease activity. These findings unveiled molecular mechanisms by which E4BP4 restrains Tfh cell differentiation, whose compromised function is associated with uncontrolled autoimmune reactions in SLE.
AB - T follicular helper (Tfh) cells are indispensable for the formation of germinal center (GC) reactions, whereas T follicular regulatory (Tfr) cells inhibit Tfh-mediated GC responses. Aberrant activation of Tfh cells contributes substantially to the pathogenesis of autoimmune diseases, such as systemic lupus erythematosus (SLE). Nonetheless, the molecular mechanisms mitigating excessive Tfh cell differentiation are not fully understood. Herein we demonstrate that the adenovirus E4 promoter-binding protein (E4BP4) mediates a feedback loop and acts as a transcriptional brake to inhibit Tfh cell differentiation. Furthermore, we show that such an immunological mechanism is compromised in patients with SLE. Establishing mice with either conditional knockout (cKO) or knockin (cKI) of the E4bp4 gene in T cells reveals that E4BP4 strongly inhibits Tfh cell differentiation. Mechanistically, E4BP4 regulates Bcl6 transcription by recruiting the repressive epigenetic modifiers HDAC1 and EZH2. E4BP4 phosphorylation site mutants have limited capability with regard to inhibiting Tfh cell differentiation. In SLE, we detected impaired phosphorylation of E4BP4, finding that this compromised transcription factor is positively correlated with disease activity. These findings unveiled molecular mechanisms by which E4BP4 restrains Tfh cell differentiation, whose compromised function is associated with uncontrolled autoimmune reactions in SLE.
UR - http://www.scopus.com/inward/record.url?scp=85087470166&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85087470166&partnerID=8YFLogxK
U2 - 10.1172/JCI129018
DO - 10.1172/JCI129018
M3 - Article
C2 - 32191636
AN - SCOPUS:85087470166
SN - 0021-9738
VL - 130
SP - 3717
EP - 3733
JO - Journal of Clinical Investigation
JF - Journal of Clinical Investigation
IS - 7
ER -